#news #biotech Pfizer/Eli Lilly’s anti-NGF osteoarthritis drug works, but FDA says safety risks ‘remained concerning’

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Pfizer/Eli Lilly’s anti-NGF osteoarthritis drug works, but FDA says safety risks ‘remained concerning’ .Pfizer/Eli Lilly’s anti-NGF osteoarthritis drug works, but FDA says safety risks ‘remained concerning’
badams
Mon, 03/22/2021 – 10:20

from FierceBiotech: Biotech https://ift.tt/3d0FScN